Alterations in the cholinergic system after frontal cortical infarction in rat brain: Pharmacological magnetic resonance imaging of muscarinic receptor responsiveness and stereological analysis of cholinergic forebrain neurons

Neurobiology of Disease

Volumn 43, Issue 3, 2011, Pages 625-634

  Hoff, Erik I ^a,b   Steinbusch, Harry W M ^b   van Oostenbrugge, Robert J ^a,b   Garrett, Lillian ^b   Otte, Willem M ^c   van der Marel, Kajo ^c   Dijkhuizen, Rick M ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Acetylcholine; PhMRI; Stereology; Stroke; Vascular cognitive impairment

Indexed keywords

CHOLINE ACETYLTRANSFERASE; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VOLUME; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL COUNT; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FOREBRAIN; FRONTAL CORTEX; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIKARYON; PRIORITY JOURNAL; RAT; STEREOMETRY;

ACETYLCHOLINE; ANIMALS; CELL COUNT; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CHOLINE O-ACETYLTRANSFERASE; FRONTAL LOBE; MAGNETIC RESONANCE IMAGING; MALE; MUSCARINIC AGONISTS; NEURONS; PILOCARPINE; RATS; RATS, INBRED LEW; RECEPTORS, MUSCARINIC; STROKE;

EID: 79960242575     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.05.011     Document Type: Article

References (54)

1. Barbelivien A., Vaussy C., Marchalant Y., Maubert E., Bertrand N., Beley A., et al. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat. J. Cereb. Blood Flow Metab. 2004, 24:1255-1266.
2. Baxter M.G., Chiba A.A. Cognitive functions of the basal forebrain. Curr. Opin. Neurobiol. 1999, 9:178-183.
3. Beckmann C.F., Smith S.M. Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans. Med. Imaging 2004, 23:137-152.
4. Bymaster F.P., McKinzie D.L., Felder C.C., Wess J. Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the phsyiological roles of the muscarinic cholinergic system. Neurochem. Res. 2003, 28:437-442.
5. Dauphin F., MacKenzie E.T. Cholinergic and vasoactive intestinal polypeptidergic innervation of the cerebral arteries. Pharmacol. Ther. 1995, 67:385-417.
6. Dawson V.L., Hsu C.Y., Liu T.H., Dawson T.M., Wamsley J.K. Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex. Exp. Neurol. 1994, 128:88-96.
7. Descarries L., Krnjevic K., Steriade M. Progress in Brain Research 2003, Vol. 145:327. Elsevier B.V., Amsterdam.
8. Dickerson B.C. Functional magnetic resonance imaging of cholinergic modulation in mild cognitive impairment. Curr. Opin. Psychiatry 2006, 19:299-306.
9. Dousset V., Ballarino L., Delalande C., Coussemacq M., Canioni P., Petry K.G., et al. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am. J. Neuroradiol. 1999, 20:223-227.
10. Elhusseiny A., Cohen Z., Olivier A., Stanimirovic D.B., Hamel E. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J. Cereb. Blood Flow Metab. 1999, 19:794-802.
11. Erkinjuntti T. Cognitive decline and treatment options for patients with vascular dementia. Acta Neurol. Scand. Suppl. 2002, 178:15-18.
12. Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia. J. Neural Transm. Suppl. 2002, 91-109.
13. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annu. Rev. Psychol. 1997, 48:649-684.
14. Goekoop R., Rombouts S.A., Jonker C., Hibbel A., Knol D.L., Truyen L., et al. Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study. Neuroimage 2004, 23:1450-1459.
15. Goekoop R., Scheltens P., Barkhof F., Rombouts S.A. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation-a pharmacological fMRI study. Brain 2006, 129:141-157.
16. Gron G., Brandenburg I., Wunderlich A.P., Riepe M.W. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. Neurobiol. Aging 2006, 27:78-87.
17. Gu W., Gu C., Jiang W., Wester P. Neurotransmitter synthesis in poststroke cortical neurogenesis in adult rats. Stem Cell Res. 2010, 4:148-154.
18. Hamel E. Cholinergic modulation of the cortical microvascular bed. Prog. Brain Res. 2004, 145:171-178.
19. Hartig W., Bauer A., Brauer K., Grosche J., Hortobagyi T., Penke B., et al. Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?. Rev. Neurosci. 2002, 13:95-165.
20. Henderson Z. Responses of basal forebrain cholinergic neurons to damage in the adult brain. Prog. Neurobiol. 1996, 48:219-254.
21. Hoff E.I., Oude Egbrink M.G., Heijnen V.V., Steinbusch H.W., van Oostenbrugge R.J. In vivo visualization of vascular leakage in photochemically induced cortical infarction. J. Neurosci. Methods 2005, 141:135-141.
22. Hoff E.I., Blokland A., Rutten K., Steinbusch H.W., van Oostenbrugge R.J. Dissociable effects in reaction time performance after unilateral cerebral infarction: a comparison between the left and right frontal cortices in rats. Brain Res. 2006, 1069:182-189.
23. Hoff E.I., van Oostenbrugge R.J., Liedenbaum M., Steinbusch H.W., Blokland A. Effects of right-hemisphere cortical infarction and muscarinic acetylcholine receptor blockade on spatial visual attention performance in rats. Behav. Brain Res. 2007, 178:62-69.
24. Hoff E.I., van Oostenbrugge R.J., Otte W.M., van der Marel K., Steinbusch H.W., Dijkhuizen R.M. Pharmacological magnetic resonance imaging of muscarinic acetylcholine receptor activation in rat brain. Neuropharmacology 2010, 58:1252-1257.
25. Hyvarinen A. Fast and robust fixed-point algorithms for independent component analysis. IEEE Trans. Neural Netw. 1999, 10:626-634.
26. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
27. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
28. Kalaria R.N., Ballard C. Stroke and cognition. Curr. Atheroscler. Rep. 2001, 3:334-339.
29. Lemmens M.A., Sierksma A.S., Rutten B.P., Dennissen F., Steinbusch H.W., Lucassen P.J., et al. Age-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer's disease. Brain Struct. Funct. 2011, Mar 16 [Epub ahead of print].
30. Liberini P., Pioro E.P., Maysinger D., Cuello A.C. Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert. Brain Res. 1994, 648:1-8.
31. Mandeville J.B., Marota J.J., Kosofsky B.E., Keltner J.R., Weissleder R., Rosen B.R., et al. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 1998, 39:615-624.
32. McKinney M., Coyle J.T. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease. Mayo Clin. Proc. 1991, 66:1225-1237.
33. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983, 10:1185-1201.
34. Mizobuchi H. Changes in muscarinic cholinergic receptor and choline acetyltransferase in experimental ischemic brain. Nippon Geka Hokan 1989, 58:93-106.
35. Nagasawa H., Araki T., Kogure K. Alteration of muscarinic acetylcholine binding sites in the postischemic brain areas of the rat using in vitro autoradiography. J. Neurol. Sci. 1994, 121:27-31.
36. Parton A., Coulthard E., Husain M. Neuropharmacological modulation of cognitive deficits after brain damage. Curr. Opin. Neurol. 2005, 18:675-680.
37. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, New York. 4th edition.
38. Pediconi M.F., Roccamo de Fernandez A.M., Barrantes F.J. Asymmetric distribution and down-regulation of the muscarinic acetylcholine receptor in rat cerebral cortex. Neurochem. Res. 1993, 18:565-572.
39. Peterson D.A., Dickinson-Anson H.A., Leppert J.T., Lee K.F., Gage F.H. Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75. J. Comp. Neurol. 1999, 404:1-20.
40. Rasquin S.M., Verhey F.R., Lousberg R., Winkens I., Lodder J. Vascular cognitive disorders: memory, mental speed and cognitive flexibility after stroke. J. Neurol. Sci. 2002, 203-204:115-119.
41. Rasquin S.M., Lodder J., Ponds R.W., Winkens I., Jolles J., Verhey F.R. Cognitive functioning after stroke: a one-year follow-up study. Dement. Geriatr. Cogn. Disord. 2004, 18:138-144.
42. Roman G.C. Facts, myths, and controversies in vascular dementia. J. Neurol. Sci. 2004, 226:49-52.
43. Rombouts S.A., Barkhof F., Van Meel C.S., Scheltens P. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2002, 73:665-671.
44. Salmeron B.J., Stein E.A. Pharmacological applications of magnetic resonance imaging. Psychopharmacol. Bull. 2002, 36:102-129.
45. Schmitz C., Born M., Dolezel P., Rutten B.P., de Saint-Georges L., Hof P.R., Korr H. Prenatal protracted irradiation at very low dose rate induces severe neuronal loss in rat hippocampus and cerebellum. Neuroscience 2005, 130:935-948.
46. Scremin O.U., Jenden D.J. Cholinergic control of cerebral blood flow in stroke, trauma and aging. Life Sci. 1996, 58:2011-2018.
47. Sofroniew M.V., Pearson R.C. Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in the rat. Brain Res. 1985, 339:186-190.
48. Sofroniew M.V., Pearson R.C., Eckenstein F., Cuello A.C., Powell T.P. Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage. Brain Res. 1983, 289:370-374.
49. Sofroniew M.V., Pearson R.C., Powell T.P. The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration. Brain Res. 1987, 411:310-331.
50. Sophou S., Dori I., Antonopoulos J., Parnavelas J.G., Dinopoulos A. Apoptosis in the rat basal forebrain during development and following lesions of connections. Eur. J. Neurosci. 2006, 24:573-585.
51. Vacca L.L. Laboratory Manual of Histochemistry 1985, Raven Press, New York.
52. Venneri A. Imaging treatment effects in Alzheimer's disease. Magn. Reson. Imaging 2007, 25:953-968.
53. Waller S.B., Nyberg P., Dietz N.J. Temporal profile of neurochemical recovery following injury by transient cerebral ischemia. J. Gerontol. A Biol. Sci. Med. Sci. 1995, 50:B307-B314.
54. Woolrich M.W., Ripley B.D., Brady M., Smith S.M. Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 2001, 14:1370-1386.